Trials / Completed
CompletedNCT02562872
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
Proof-of-concept, Single Center Study in Healthy Adult Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Prophylactic Activity of Single Dose DSM265 in a Controlled Human Malarial Infection Challenge Either by Direct Venous Inoculation of Plasmodium Falciparum Sporozoites or Mosquito-borne Plasmodium Falciparum
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Medicines for Malaria Venture · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is a single centre, randomised, placebo-controlled, double-blind study with DSM265 including up to two cohorts of healthy male and female volunteers aged 18 to 45 years. The study will be conducted into two sequential parts (Cohort 1 and Cohorts 2a and 2b).
Detailed description
Cohort 1: * Controlled human malaria infection on Day 0 (Direct Venous Inoculation of 3200 cryopreserved Plasmodium falciparum sporozoites) * Drug administration on Day -3 * 8 subjects: 6 DSM265 400 mg: 2 matching placebo Clinical safety review of Cohort 1 in order to proceed to Cohorts 2a and 2b Cohort 2a: * Controlled human malaria infection on Day 0 (Direct Venous Inoculation of 3200 cryopreserved Plasmodium falciparum sporozoites) * Drug administration on Day -X (to be defined following safety and pharmacokinetic data) * 8 subjects: 6 DSM265 400 mg: 2 matching placebo Cohort 2b: * Controlled human malaria infection on Day 0 (infected mosquito bite) * Drug administration on Day -X (to be defined following safety and pharmacokinetic data) * 8 subjects: 6 DSM265 400 mg: 2 matching placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DSM265 | DSM265 400 mg single oral dose |
| DRUG | Placebo | Placebo to match DSM265, single oral dose |
| BIOLOGICAL | Sporozoites | Direct venous inoculation of 3200 cryopreserved Plasmodium falciparum (NF54 strain) sporozoites |
| BIOLOGICAL | Infective mosquito bite | Five single bites by laboratory reared female Anopheles stephensi mosquitoes carrying Plasmodium falciparum |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2015-09-29
- Last updated
- 2022-01-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02562872. Inclusion in this directory is not an endorsement.